Haematologica (Aug 2024)
Ponatinib alone or with chemo-immunotherapy in heavily pre-treated Philadelphia-like acute lymphoblastic leukemia: a CAMPUS ALL real-life study
- Francesca Kaiser,
- Monia Lunghi,
- Deborah Cardinali,
- Vittorio Bellomarino,
- Marco Beldinanzi,
- Irene Della Starza,
- Francesco Malfona,
- Claudia M. Basilico,
- Marzia Defina,
- Sara Mastaglio,
- Fabio Giglio,
- Davide Lazzarotto,
- Prassede Salutari,
- Matteo Piccini,
- Valeria Cardinali,
- Antonio Pierini,
- Nicola S. Fracchiolla,
- Federica Di Biase,
- Mario Annunziata,
- Mariangela Di Trani,
- Robin Foa,
- Sabina Chiaretti
Affiliations
- Francesca Kaiser
- Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome
- Monia Lunghi
- Division of Hematology, Department of Translational Medicine, AOU Maggiore della Carità, Università del Piemonte Orientale, Novara
- Deborah Cardinali
- Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome
- Vittorio Bellomarino
- Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome
- Marco Beldinanzi
- Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome
- Irene Della Starza
- Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy; AIL ROMA ODV, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome
- Francesco Malfona
- Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome
- Claudia M. Basilico
- Hematology Department, ASST Settelaghi, Ospedale di Circolo - Fondazione Macchi, Varese
- Marzia Defina
- Hematology Department, Azienda Ospedaliera Universitaria Senese, Siena
- Sara Mastaglio
- San Raffaele Scientific Institute, Department of Onco-Hematology, Milan
- Fabio Giglio
- San Raffaele Scientific Institute, Department of Onco-Hematology, Milan
- Davide Lazzarotto
- Division of Hematology and SCT, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), University Hospital of Udine
- Prassede Salutari
- Hematology Department, Ospedale Civile Pescara
- Matteo Piccini
- Hematology Department, Azienda Ospedaliero-Universitaria Careggi, Florence
- Valeria Cardinali
- Section of Hematology, Department of Medicine and Surgery, Center for Hemato-Oncological Research (CREO), University of Perugia, Perugia
- Antonio Pierini
- Section of Hematology, Department of Medicine and Surgery, Center for Hemato-Oncological Research (CREO), University of Perugia, Perugia
- Nicola S. Fracchiolla
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan
- Federica Di Biase
- Department of Molecular Biotechnology and Health Sciences, Division of Hematology, University of Torino, Torino
- Mario Annunziata
- Hematology Department, Moscati Hospital, Aversa
- Mariangela Di Trani
- Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome
- Robin Foa
- Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome
- Sabina Chiaretti
- Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome
- DOI
- https://doi.org/10.3324/haematol.2024.285258
- Journal volume & issue
-
Vol. 999,
no. 1
Abstract
Not available.
